300 related articles for article (PubMed ID: 19584104)
21. Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins.
Soustre J; Rodier MH; Imbert-Bouyer S; Daniault G; Imbert C
J Antimicrob Chemother; 2004 Mar; 53(3):522-5. PubMed ID: 14749343
[TBL] [Abstract][Full Text] [Related]
22. In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections.
Seidler M; Salvenmoser S; Müller FM
Int J Antimicrob Agents; 2006 Dec; 28(6):568-73. PubMed ID: 17101265
[TBL] [Abstract][Full Text] [Related]
23. The radish defensins RsAFP1 and RsAFP2 act synergistically with caspofungin against Candida albicans biofilms.
Vriens K; Cools TL; Harvey PJ; Craik DJ; Braem A; Vleugels J; De Coninck B; Cammue BP; Thevissen K
Peptides; 2016 Jan; 75():71-9. PubMed ID: 26592804
[TBL] [Abstract][Full Text] [Related]
24. In vivo efficacy of anidulafungin against mature Candida albicans biofilms in a novel rat model of catheter-associated Candidiasis.
Kucharíková S; Tournu H; Holtappels M; Van Dijck P; Lagrou K
Antimicrob Agents Chemother; 2010 Oct; 54(10):4474-5. PubMed ID: 20660685
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice.
Najvar LK; Bocanegra R; Wiederhold NP; Lambros C; Najarian N; Patterson TF; Graybill JR
Clin Microbiol Infect; 2008 Jun; 14(6):595-600. PubMed ID: 18397335
[TBL] [Abstract][Full Text] [Related]
26. Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces.
Katragkou A; Roilides E; Walsh TJ
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S622-9. PubMed ID: 26567280
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.
Kovács R; Nagy F; Tóth Z; Bozó A; Balázs B; Majoros L
Lett Appl Microbiol; 2019 Oct; 69(4):271-278. PubMed ID: 31385615
[TBL] [Abstract][Full Text] [Related]
28. Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro.
Harris MR; Coote PJ
Int J Antimicrob Agents; 2010 Apr; 35(4):347-56. PubMed ID: 20106636
[TBL] [Abstract][Full Text] [Related]
29. Efficacies of caspofungin and a combination of caspofungin and meropenem in the treatment of murine disseminated candidiasis.
Ozcan SK; Budak F; Willke A; Filiz S; Costur P; Dalcik H
APMIS; 2006 Dec; 114(12):829-36. PubMed ID: 17207082
[TBL] [Abstract][Full Text] [Related]
30. Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms.
Srinivasan A; Gupta CM; Agrawal CM; Leung KP; Lopez-Ribot JL; Ramasubramanian AK
Biotechnol Bioeng; 2014 Feb; 111(2):418-24. PubMed ID: 24114441
[TBL] [Abstract][Full Text] [Related]
31. A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.
Nieminen MT; Novak-Frazer L; Rautemaa W; Rajendran R; Sorsa T; Ramage G; Bowyer P; Rautemaa R
PLoS One; 2014; 9(7):e101859. PubMed ID: 24991987
[TBL] [Abstract][Full Text] [Related]
32.
Jiang L; Zheng L; Sun KA; Zhou P; Xu R; Gu J; Wei X
Biofouling; 2020 May; 36(5):537-548. PubMed ID: 32551919
[No Abstract] [Full Text] [Related]
33. Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: importance of persistence of caspofungin in tissues to understanding drug activity.
Louie A; Deziel M; Liu W; Drusano MF; Gumbo T; Drusano GL
Antimicrob Agents Chemother; 2005 Dec; 49(12):5058-68. PubMed ID: 16304173
[TBL] [Abstract][Full Text] [Related]
34. Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.
Colombo AL; Ngai AL; Bourque M; Bradshaw SK; Strohmaier KM; Taylor AF; Lupinacci RJ; Kartsonis NA
Antimicrob Agents Chemother; 2010 May; 54(5):1864-71. PubMed ID: 20231388
[TBL] [Abstract][Full Text] [Related]
35. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates.
Shuford JA; Piper KE; Steckelberg JM; Patel R
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):277-81. PubMed ID: 17141454
[TBL] [Abstract][Full Text] [Related]
36. Sequential therapy with caspofungin and fluconazole for Candida albicans infection.
Barchiesi F; Spreghini E; Baldassarri I; Marigliano A; Arzeni D; Giannini D; Scalise G
Antimicrob Agents Chemother; 2004 Oct; 48(10):4056-8. PubMed ID: 15388480
[TBL] [Abstract][Full Text] [Related]
37. Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms.
Mukherjee PK; Long L; Kim HG; Ghannoum MA
Int J Antimicrob Agents; 2009 Feb; 33(2):149-53. PubMed ID: 18945596
[TBL] [Abstract][Full Text] [Related]
38. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model.
Goldblum D; Frueh BE; Sarra GM; Katsoulis K; Zimmerli S
Antimicrob Agents Chemother; 2005 Apr; 49(4):1359-63. PubMed ID: 15793112
[TBL] [Abstract][Full Text] [Related]
39. Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates.
Shirazi F; Kontoyiannis DP
Virulence; 2015; 6(4):385-94. PubMed ID: 26065323
[TBL] [Abstract][Full Text] [Related]
40. Covalent immobilization of antimicrobial agents on titanium prevents Staphylococcus aureus and Candida albicans colonization and biofilm formation.
Kucharíková S; Gerits E; De Brucker K; Braem A; Ceh K; Majdič G; Španič T; Pogorevc E; Verstraeten N; Tournu H; Delattin N; Impellizzeri F; Erdtmann M; Krona A; Lövenklev M; Knezevic M; Fröhlich M; Vleugels J; Fauvart M; de Silva WJ; Vandamme K; Garcia-Forgas J; Cammue BP; Michiels J; Van Dijck P; Thevissen K
J Antimicrob Chemother; 2016 Apr; 71(4):936-45. PubMed ID: 26702917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
